Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 1 May 1998:
Vol. 280. no. 5364, pp. 667 - 668
DOI: 10.1126/science.280.5364.667
Prev | Table of Contents | Next

News & Comment

GENOME RESEARCH:
Private Help for a Public Database?

Eliot Marshall

The National Institutes of Health (NIH) has pledged $30 million to create a public database of genome markers called single nucleotide polymorphisms (SNPs), but it's unknown whether private companies, which are likely to generate vast quantities of SNPs, will also join in. Worried that NIH's planned expenditure for SNPs collection may not be adequate to move the field forward as rapidly as possible, a retired vice president from the pharmaceutical firm Merck & Co. Inc. organized a private meeting of drug company executives on 8 April in New York City to try to interest them in contributing "in cash or in kind" to a public SNPs database. How well his plea is succeeding may be evident at a second meeting he is planning later this month.

Read the Full Text

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)